Read More

Achieve Life Sciences Announces Publication Of Cytisinicline Vaping Cessation Trial Results In JAMA Internal Medicine; Phase 2 ORCA-V1 Trial Showed Treatment With Cytisinicline More Than Doubled Odds Of Quitting E-Cigarettes Compared With Placebo

Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo   Cytisinicline treatment well tolerated with no serious adverse events

ACHV

Read More

Why Food Processing Firm TreeHouse Foods Shares Are Diving Today

TreeHouse Foods faces a dip in shares following revenue drop and a missed EPS estimate. Q1 FY24 sales hit $820.70 million, exceeding expectations despite the decline. The decrease stems from planned exits in coffee and bakery segments, and a facility restart, contributing to a 440 basis points Y/Y contraction in gross margin.

THS